Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the malaria treatment market grown over the years?

The size of the market for malaria treatment has been witnessing steady growth in the past few years. It is projected to rise from $1.55 billion in 2024 to reach $1.62 billion in 2025, expanding at a compound annual growth rate (CAGR) of 4.9%. The past growth can be accredited to the development of potent drugs, efforts towards vector control, worldwide health campaigns, advancements in scientific research, and the expansion of health infrastructure.

What Is the forecasted market size and growth rate for the malaria treatment market?

In the coming years, the market for malaria treatment is projected to witness robust expansion. By 2029, it is set to reach $2.07 billion, with a compound annual growth rate (CAGR) of 6.3%. Factors contributing to this growth during the forecasted period include monitoring of drug resistance, the effects of climate change, the implementation of precision medicine and genomic strategies, amendments in healthcare financing, and the incorporation of digital health solutions. The forecast period will also see major trends such as enhancement of epidemiological surveillance, integration of alternative medicine, advancement in malaria vaccine, implementation of data-informed treatment programs, and initiation of education and training programs.

Get your malaria treatment market report here!

https://www.thebusinessresearchcompany.com/report/malaria-treatment-global-market-report

What are the major factors driving growth in the malaria treatment market?

The rising number of malaria cases is predicted to boost the malaria treatment market’s expansion in the future. Malaria, a potentially fatal ailment transmitted by mosquitoes, is caused by the Plasmodium parasite and marked by a recurrent fever and other symptoms resembling the flu. This surge can be attributed to factors like poverty, inadequate healthcare facilities, climate alterations, absence of measures controlling malaria, and resistance to drugs. Malaria treatment contributes to the effective handling and healing of the infection instigated by the Plasmodium parasite. For example, as per the World malaria report 2023 conducted by the World Health Organization, a Switzerland-headquartered intergovernmental body, global instances of malaria touched 249 million in 2022, demonstrating an increase of five million in contrast to 2021. Hence, the escalating prevalence of malaria fuels the growth of the malaria treatment market.

What key areas define the segmentation of the global malaria treatment Market?

The malaria treatment market covered in this report is segmented –

1) By Treatment: Prescription Medications, Vaccines, Diagnostic Tests, Other Treatments

2) By Route Of Administration: Oral, Parenteral, Intravenous

3) By Distribution Channel: Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

4) By End User: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegments:

1) By Prescription Medications: Antimalarial Drugs, Prophylactic Medications

2) By Vaccines: RTS,S Or AS01, Other Experimental Vaccines

3) By Diagnostic Tests: Rapid Diagnostic Tests, Microscopy-Based Tests, Polymerase Chain Reaction (PCR) Tests

4) By Other Treatments: Supportive Care, Herbal Remedies, Vector Control Measures

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11939&type=smp

What are the top market players propelling the growth of the malaria treatment industry?

Major companies operating in the malaria treatment market include Pfizer Inc., Merck & Co., Johnson & Johnson, Roche Holding AG, Bayer AG, Novartis AG, Sanofi SA, AstraZeneca Plc, GlaxoSmithKline PLC., Takeda Pharmaceutical Company Limited, Sumitomo Chemical Co. Ltd., Viatris Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Serum Institute of India, Cipla Ltd., Amneal Pharmaceuticals LLC, Lupin Ltd., Zydus Lifesciences Limited, Ipca Laboratories Ltd., Chongqing Holley Pharmaceutical Co. Ltd., Zydus Lifesciences Ltd., Medicines Sans Frontières, Strides Pharma Science Limited, Swiss Tropical and Public Health Institute (Swiss TPH), AdvaCare Pharma USA LLC, Medicines for Malaria Venture (MMV), VLP Therapeutics LLC, Actiza Pharmaceutical Private Limited

What are the key trends shaping the future of the malaria treatment market?

Leading organizations in the malaria treatment market are creating techniques such as the VERV Program to boost the performance and efficacy of diagnostics and treatments for malaria, with the ultimate purpose of lessening the disease’s impact in areas where it is prevalent. Launched by EPA, the Vector Expedited Review Voucher (VERV) Program, an initiative that promotes the production of fresh mosquito control products to combat illnesses like malaria, offers faster review vouchers for registration purposes. For example, in December 2023, the Environmental Protection Agency (EPA), a US governmental entity, initiated the VERV Program. Financial incentives will be offered by the VERV Program to companies that invent new pesticides targeted specifically at mosquito populations that have developed resistance to conventional insecticides. The program will ensure quicker registration procedures for suitable products, thus hastening their arrival in the marketplace.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11939

What regions are dominating the malaria treatment market growth?

Middle East and Africa was the largest region in the malaria treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the malaria treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Medical Equipment Maintenance Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-equipment-maintenance-global-market-report

Biosimilar Therapeutic Peptides Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biosimilar-therapeutic-peptide-global-market-report

Medication Adherence Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medication-adherence-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: